Apex Medical Corporation, a $75 million company and a major player in the respiratory therapy and pressure area care sectors, has made its debut into Indian market with the launch of its three main product verticals - respiratory, support surface and autoclaves primarily as their core offering in India.

The company has a long term plan for the Indian market and will proceed in phases in a strategic manner, Apex said.

In the next few years, with an aggressive growth plan, Apex in India expects to grow at a CAGR of 30 percent.

Founded in the year 1990, Apex Medical is headquartered in Taiwan, the company caters to Europe, United States, Asia and other international markets through an established network of international subsidiaries and partners.

Apex invests 5 percent of its annual revenue into R&D.